Navigation Links
Next Safety Releases Advanced Respirator for Infectious Diseases
Date:8/5/2009

/p>

Next Safety is also developing other pulmonary drug delivery platforms for inhaled antibiotics and anti-medics, concentrated narcotics and drugs to treat pulmonary conditions such as asthma, COPD and the immune compromised.

The doctors, scientists and engineers who work for Next Safety have developed the most comprehensive and effective solution for the pulmonary delivery of medicines to in-home patients and persons who are addicted to smoking cigarettes. The company is developing combined respirator and pulmonary drug delivery systems for soldiers to have highly sophisticated medical care that greatly enhances their likely hood of survival in battle.

Next Safety engineers are experts in high-volume manufacturing. The company's engineers and managers have made more than 40 million electrical devices a month for years. These are products that are designed to protect babies and children.

Next Safety has invested in significant capacity for pandemic stockpiling. The company expects to build approximately 5 million respirators for delivery in December 2009 and has the capacity to build 300 million respirators a month for pandemic stockpiling by March 2010.

Next Safety thanks the doctors and staff at Italy's level-4 Milan biological research center for helping it design the best respirators for pandemic stockpiling.

Next Safety's advanced respirator product line is available at http://www.nextsafety.com.

    Contact:

    Eric Hunter
    336-246-7700
   http://www.nextsafety.com

This release was issued through eReleases(TM). For more information, visit '/>"/>

SOURCE Next Safety, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Elagolix Successful in Six Month Lilac Petal Study; Safety and Efficacy Confirmed in Patients With Endometriosis
2. Improving Transfusion Safety: Fenwal, Verax Biomedical Sign Agreement for Rapid, Point-of-Care Bacteria Test
3. Inspiration Biopharmaceuticals Presents Safety Data on IB1001, a Novel Recombinant Factor IX for the Treatment of Hemophilia at the International Society on Thrombosis and Haemostasis (ISTH) Annual Meeting
4. MacroGenics Announces the Initiation of a Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Monoclonal Antibody MGAWN1 in Subjects with Suspected Central Nervous System Infection Due to West Nile Virus
5. EFSA Issues Positive Safety Statement for the Use of Chromium Picolinate in EU Food Supplements
6. AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule
7. iCardiac Selected for Multiple Cardiac Safety Studies
8. Assessment of safety and efficacy of human embryonic stem cell therapy
9. Neurim Pharmaceuticals Reports Long Term Efficacy and Safety for Circadin(R) for Insomnia in Elderly Patients
10. OncoGenex Pharmaceuticals Announces OGX-427 Treatment Demonstrates Safety, Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Markers in a Phase 1 Cancer Trial
11. Leaders in Health Literacy Recognized by the Partnership for Clear Health Communication at the National Patient Safety Foundation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...0 Karolinska Development AB today,...has entered into a,co-investment agreement with th...by Karolinska Development and used to invest in th...l and medical technology companies. EIF,has agreed... The agreement,represents EIF,s largest single inv...
(Date:11/20/2009)... recently announced that a free webinar, “Ro...e Particle Characterization”, will be presen...lication of in situ particle characterization is d... series of roller compaction runs while varying ra...ces. , (PRWEB) November 2...
(Date:11/19/2009)... charge their cell phones and other personal elect...ry made by UC San Diego engineers could lead to ca...just this. , In recent research, published in ...fessor in the UCSD Department of Mechanical and Ae...ark Hoefer, have found that artificially introduce...
(Date:11/19/2009)...FirstCall/ -- Omeros Corporation (Nasdaq: OMER ) ...e third quarter ended September 30, 2009. For the ...rted a net loss of $3.9 million, or $1.34 per shar...2.54 per share, for the same period in 2008. For t...ny reported a net loss of $15.5 million, or $5.29 ...
Breaking Biology Technology:Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3Roller Compaction Process Optimization Using At-Line Particle Characterization 2Nanotube defects equal better energy and storage systems 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8
...e, Inc. (Amex: PIP ) a biodefense company develo...d chemical threats, announced today that its finan...sed on Monday, March 30, 2009. , , PharmAthene ma...uss its year end financial results. The call is s...day, March 30, 2009 and will last approximately 45...
... Real Estate Equities, Inc. (NYSE: ARE ) announc...ing of 7,000,000 shares of common stock at a price...ized offering of 4,500,000 shares. Merrill Lynch ...k-running managers and Keefe, Bruyette & Woods...tion with the public offering. Alexandria Real Es...
...t to Humulin(R) R (recombinant human, insulin),...emBioSys Genetics Inc. (TSX:SBS), specializing in ... plant seeds, today announced preliminary results ...a recombinant human insulin manufactured using its... SBS-1000 was bioequivalent to a recombinant human...
Other Biology Technology:PharmAthene To Host Year-End 2008 Earnings Conference Call and Webcast on Monday, March 30, 2009 2Alexandria Real Estate Equities, Inc. Announces Pricing of Public Follow-On Offering of 7,000,000 Shares of Common Stock 2Alexandria Real Estate Equities, Inc. Announces Pricing of Public Follow-On Offering of 7,000,000 Shares of Common Stock 3SemBioSys Genetics Inc. Announces Clinical Results with Plant-Produced Insulin 2SemBioSys Genetics Inc. Announces Clinical Results with Plant-Produced Insulin 3SemBioSys Genetics Inc. Announces Clinical Results with Plant-Produced Insulin 4
(Date:11/23/2009)..., , , , , , , ,...rew Marshall, from the Environment Department at t... Kinyongia magomberae and his wider work in Tanza...rmation. , , , , , , ... , , , , A new species of chameleon has...
(Date:11/23/2009)...itute for Child Health Research has found evidence... in pregnancy affects child behaviour in different...e in the international journal Addiction . , Le...awn from a random sample of more than 2000 mothers...the baby,s delivery, and were then followed up whe...
(Date:11/23/2009)... , A bit of imagination on the part of a meas... help to add data from areas where the instrument ...ructively. In order to infer missing data in an as...tion, physicists at the Max Planck Institute for A...rception called information field theory. The scie...
Breaking Biology News(10 mins):New chameleon species discovered in East Africa 2New chameleon species discovered in East Africa 3New study links alcohol in pregnancy to child behavior problems 2Visual assistance for cosmic blind spots 2Visual assistance for cosmic blind spots 3Visual assistance for cosmic blind spots 4CenterWatch Honored a Fifth Consecutive Year for Best Healthcare Content 14779 1CenterWatch Honored a Fifth Consecutive Year for Best Healthcare Content 14779 2Reportlinker Adds Infections Throat Infection 61072 1Reportlinker Adds Infections Throat Infection 61072 2Reportlinker Adds Infections Throat Infection 61072 3Reportlinker Adds US World Nutraceutical Ingredients Industry 61069 1Reportlinker Adds US World Nutraceutical Ingredients Industry 61069 2Reportlinker Adds US World Nutraceutical Ingredients Industry 61069 3Reportlinker Adds US World Nutraceutical Ingredients Industry 61069 4Reportlinker Adds US World Nutraceutical Ingredients Industry 61069 5Reportlinker Adds US World Nutraceutical Ingredients Industry 61069 6Reportlinker Adds US World Nutraceutical Ingredients Industry 61069 7Reportlinker Adds US World Nutraceutical Ingredients Industry 61069 8Reportlinker Adds US World Nutraceutical Ingredients Industry 61069 9Reportlinker Adds US World Nutraceutical Ingredients Industry 61069 10Reportlinker Adds US World Nutraceutical Ingredients Industry 61069 11Reportlinker Adds US World Nutraceutical Ingredients Industry 61069 12Reportlinker Adds US World Nutraceutical Ingredients Industry 61069 13
...lecule thought crucial to ferrying the deadly rabi..., apparently isn’t. The surprising finding, say re...phia, may change the way scientists think about ho... herpes viruses invade the brain and cause disease...or of microbiology and immunology at Jefferson Med...
...nt discoveries by researchers at the Uniformed Ser...d lead to new avenues of exploration for radioprot..., an associate professor in USU,s Department of Pa...e pointing to the mechanism through which the extr...protects itself from high doses of ionizing radiat...
...as been speculated that lead poisoning may have pl... thought to have been caused by the concentration ...oduction of lead-free gasoline has reduced damage ...continues to increase worldwide because lead is st...nents. However, there has thus far been little res...
Other Biology News:Jefferson researchers' discovery may change thinking on how viruses invade the brain 2Researchers uncover protection mechanism of radiation-resistant bacterium 2Lead with a poisonous electron shield 2
...vacuum concentrator/centrifugal evaporator systems...logy and biochemistry for rapid and safe concentra... expanded with pumps, different of cold traps and ...s by transfer), ensuring solvent recovery and samp...
Explorer Software Suite. Complete software and PC for datalogging, programming, control and monitoring for Explorer SpeedVac System [please inquire for latest PC configuration] from Thermo Scientific
MBS Thermal Cycler 1 Block Laptop Kit from Thermo Scientific
HeavyPeptide Basic Kit from Thermo Scientific
Biology Products: